Skip to main content
Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive117AccountSocial
MARKETSINVESTLIVE117
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Medicine

When will the FDA reclassify BPC-157 to Category 1?

AI Digest · FDA decision on BPC-157 before 2027 keeps losing ground as the month closes

Not advice · 3d ago
Chance
Before 2027
7%
▼ 1

Before 2027

7%
▼ 1
Before September
No

Before September

No
Before November
No

Before November

No
3 more
When will the FDA reclassify BPC-157 to Category 1?

Before 2027

Odds
7% chance
Max payout
Dec 31, 2026
$0
$146,961 vol
More Science and Technology Markets

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?DeepSeek market share this weekGoogle market share this weekOpenAI market share this weekOpen vs. Closed Token Volume (open weights share) in Nov 12, 2026Anthropic market share this weekWhich AI company will have the best coding model at the end of 2026?

Science and Technology hub

All Science and Technology markets